Finance

Lists
Why is ACCV down 13.62%?
Dive Deeper
ACCV:NASDAQ
Accelevation Holdings Corp
$9.58
-13.62%
(-1.51) 1D
Nov 20, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACCV...
Open
$10.90
High
$10.90
Low
$8.82
Mkt. cap
2.16B
Avg. vol.
1.42M
Volume
1.67M
P/E ratio
56.02
52-wk high
$18.10
52-wk low
$8.82
EPS
$0.17
No. of employees
2K
Open
$10.90
High
$10.90
Low
$8.82
Mkt. cap
2.16B
Avg. vol.
1.42M
Volume
1.67M
P/E ratio
56.02
52-wk high
$18.10
52-wk low
$8.82
EPS
$0.17
No. of employees
2K
News stories
From web sources and news partners
About Accelevation Holdings Corp
CEO-
Employees1.72K
Founded2017
HeadquartersMiamisburg, Ohio, United States
SectorIndustrials
Industrycapital good
Analyst ratings
Based on 8 analysts giving stock ratings to ACCV in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ACCV in the last 3 months.
Highest
Current $9.58
$20.00 (+108.77%)
Average
$19.00 (+98.33%)
Lowest
$16.00 (+67.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joe Ritchie
Goldman Sachs
Hold
Maintained
$20.00
+108.8%
11/19/2026
Erik Woodring
Morgan Stanley
Hold
Reiterated
$18.00
+87.9%
11/17/2026
Guy Hardwick
Barclays
Buy
Maintained
$20.00
+108.8%
11/13/2026
Andrew Obin
Bank of America Securities
Buy
Reiterated
$20.00
+108.8%
11/13/2026
Nigel Coe
Wolfe Research
Buy
Initiated
-
-
10/26/2026
Brian Drab
William Blair
Buy
Initiated
-
-
10/26/2026
Luke Junk
Robert W. Baird
Buy
Initiated
$16.00
+67%
10/26/2026
Tomohiko Sano
J.P. Morgan
Buy
Initiated
$20.00
+108.8%
10/25/2026
Last report
Nov 13, 2026
Fiscal period
Q3 2026
- / $0.08
Revenue / Est. (USD)
202.22M / 200.00M
+1.11%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
121.89M
255.99M
181.46M
202.22M
Cost of goods sold
79.76M
188.23M
133.07M
143.06M
Cost of revenue
79.76M
188.23M
133.07M
143.06M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.02M
25.58M
23.68M
27.20M
Operating expense
24.06M
34.50M
32.12M
40.97M
Total operating expenses
103.82M
222.73M
165.20M
184.03M
Operating income
18.07M
33.26M
16.27M
18.20M
Other non operating income
1.41M
188.00K
-452.00K
345.00K
EBT including unusual items
13.93M
22.23M
-1.96M
3.15M
EBT excluding unusual items
13.93M
26.53M
8.00M
3.15M
Income tax expense
284.00K
460.00K
484.00K
-2.00K
Effective tax rate
2.04%
2.07%
-24.68%
-0.06%
Other operating expenses
-
-
-
-
Net income
13.65M
21.60M
-2.78M
2.93M
Net profit margin
11.20%
8.44%
-1.53%
1.45%
Earnings per share
-
-
-
-
Interest and investment income
123.00K
173.00K
369.00K
657.00K
Interest expense
-5.67M
-7.09M
-8.19M
-16.05M
Net interest expenses
-5.55M
-6.92M
-7.82M
-15.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.26M
42.92M
25.67M
49.71M
Gain or loss from assets sale
-
-
2.13M
-2.13M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps